Here, we found that low expression of NEIL3, CDC25C, and NEK2 predicted high RFS and OS respectively (p < 0.05), and low expression of HCN2 predicted high OS (p < 0.05) in all breast cancer. Here, NEIL3 is linked to breast carcinoma.